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Summary
Background.— Despite the availability of effective devices, percutaneous closure of patent
ductus arteriosus (PDA) can be challenging in some situations.
Aim.— To describe our initial experience of percutaneous PDA closure.
Methods.— Between 2001 and 2007, 73 consecutive patients aged 3months to 70 years under-
went transcatheter PDA closure. An Amplatzer duct occluder (ADO) was chosen for ducts greater
than 2mm (n = 50) and a Detachable coil (DC) for smaller ducts (n = 23).
Results.— The diameter of the ducts ranged from 1 to 7.2 (mean 2.9± 1.3) mm. The prostheses
were implanted successfully in all patients. The complete closure rate reached 98% in the ADO
group and 100% in the DC group at 12months. Four (5.4%) patients showed asymptomatic device
protrusion: three patients (5, 6 and 10 kg) into the aortic isthmus and one patient (7 kg) into
the pulmonary artery (PA). One patient (7 kg) experienced transient severe bradycardia due
to pulmonary air embolism. Another patient (3.3 kg) had a permanent asymptomatic occlusion
of the femoral artery. In a third patient (17 kg), the ADO migrated asymptomatically into the
descending aorta and was discovered 12months later.
∗ Corresponding author. Fax: +9611615300 ext 9706.
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Chez les tous petits patients, l’ADO pourrait entraîner une obstruction au niveau de l’aorte
ou de l’artère pulmonaire, ou une migration de la prothèse. La recherche minutieuse des
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bréviations
DO Amplatzer duct occluder
C detachable coil
A pulmonary artery
DA patent ductus arteriosus
ackground
atent ductus arteriosus (PDA) is a common congenital
eart defect that is usually identiﬁed in childhood but
ometimes remains unrecognized until late in life. Since
he ﬁrst successful attempt at percutaneous closure by
ortsmann in 1967 [1], a number of different devices
ave been developed and evaluated, and percutaneous
DA closure has now become the treatment of choice in
dults and children weighing more than 3 kg. The two
evices used most frequently are the Flipper Detachable
oil (DC; Cook cardiology, Bloomington, IN, USA) and the
mplatzer duct occluder (ADO; AGA Medical, Golden Val-
ey, MN, USA), the former being indicated for closure of
mall PDAs and the latter for moderate to large PDAs
2—10].Despite the availability of these effective devices,
ome situations remain challenging, especially when
mall infants and/or large PDAs are involved. More-
ver, increasing experience with transcatheter techniques
as resulted in interventional cardiologists attempting
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irtout chez les petits enfants et en cas de large canal.
s droits réservés.
ore frequently to treat patients with PDAs of more
omplex morphology. Our paediatric cardiology unit was
reated in 2002 in a medium-sized university hospital with
00mixed beds (paediatric and adult). Here, we describe
ur initial experience of percutaneous PDA closure in
ll consecutive patients during the unit’s ﬁrst 5 years,
mphasizing the difﬁculties, solutions, complications and
utcomes.
atients and methods
ll consecutive patients who underwent an attempt at tran-
catheter PDA closure in our unit between january 2002 and
ecember 2007 were included in this study. The minimum
equired weight was 3 kg for the use of a DC and 5 kg for an
DO. All babies who weighed less than 3 kg were referred for
urgery. All infants who weighed less than 5 kg and required
n ADO (based on the ﬁnding of a large PDA [> 2mm] on
ransthoracic echocardiography) were also referred to the
urgeon (ﬁve patients during this period). Informed written
onsent was obtained from all adult patients and children’s
arents.
All percutaneous interventions were performed by theZ. Saliba et al.
Conclusion.— Even during the learning curve, percutaneous PDA closure can give excellent
results. Strict adherence to protocols and careful follow-up assessments are mandatory. In small
infants, the use of the ADO may lead to obstruction in the aorta or PA, or to device migration.
Cautious surveillance for untoward events is essential, especially in small infants with large
ducts.
© 2008 Elsevier Masson SAS. All rights reserved.
Résumé
Objectifs.— Cette étude décrit les débuts de notre expérience dans la fermeture percutanée
du canal artériel perméable.
Méthodes.— Entre 2001 et 2007, 73 patients consécutifs âgés de trois mois à 70 ans, ont eu une
fermeture percutanée du canal artériel. Un Amplatzer duct occluder (ADO) a été utilisé pour
le canal supérieur à 2mm et un Coil détachable (DC) pour le canal inférieur à 2mm.
Résultats.— Le diamètre du canal a varié 1 à 7.2mm (moyenne 2.9± 1.3mm). Un ADO a été
utilisé chez 50 patients (68 %), et un DC chez 23 patients. Les prosthèses ont été implantées avec
succès chez tous les patients, avec une fermeture complète du canal à 12mois dans 98 % des
cas dans le groupe ADO et 100% des cas dans le groupe DC. Quatre patients (5.4 %) ont montré
une protrusion asymptomatique de la prothèse : dans l’isthme aortique chez trois patients de
5, 6, et 10 kg et dans l’artère pulmonaire chez un patient de 7 kg. Un patient de 7 kg a présenté
une bradycardie transitoire sévère, due à une embolie pulmonaire gazeuse. Un autre patient
de 3.3 kg a présenté une occlusion asymptomatique de l’artère fémorale. Chez un troisième
patient de 17 kg, l’ADO a migré du canal artériel jusqu’à l’aorte descente, où il fut découvert
12mois plus tard.
Conclusion.— Même au cours de la période d’apprentissage, cette procédure peut avoir
d’excellents résultats. L’adhésion stricte aux protocoles et un suivi rigoureux sont nécessaires.ame operator (ZS). After obtaining arterial femoral access,
n aortogram was performed in the lateral projection to
eﬁne the morphology and the size of the duct. Arte-
ial femoral access could not be obtained in two infants,
n whom the procedure was performed only through the
arteriosus 113
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femoral vein. A sizing balloon was needed for accurate
measurement in two adult patients with large window-like
ducts.
An ADO was chosen when the PDA was greater than 2mm.
The only exception to this rule was a 70-year-old patient
with a 3mm PDA; a 6/4 size ADO was not available and two
coils were then deployed to close the duct. When an ADO
was used, the selected size was usually 2 to 3mm larger
than the minimum ductal diameter and it was deployed
transvenously in all cases. A DC was selected for closure of
small (< 2mm) PDAs. The size of the DC was 2 to 2.5 times
wider than the narrowest ductal diameter and long enough
to produce at least two loops inside the ductal ampulla. The
DC was implanted transarterially in all but one patient who
did not have an arterial access. Our protocol and technical
details for duct closure have been described in a previous
publication [9].
A repeat aortogram was obtained 10min after releasing
the device, to check for residual shunts and any anomaly
in the device position. This post-procedural aortogram was
replaced by an immediate echocardiographic assessment in
the two patients without arterial access. The procedure was
carried out under general anaesthesia in paediatric patients
and under local anaesthesia in adults. An intravenous bolus
injection of 50 IU/kg heparin was administered after obtain-
ing vascular access. The activated clotting time was not
measured. All patients received one prophylactic dose of
cephazolin (30mg/kg) before the procedure.
On the next day, before discharge, the location of the
device was noted on a plain chest X-ray, which was checked
in most cases by the paediatric resident. A repeat cardiac
ultrasound scan was also performed by one of the three pae-
diatric cardiologists —usually the one who had recruited the
patients— to check for the presence and degree of any resid-
ual shunt and to detect any possible change in the device
position. Systematic urine analysis, to check for haemol-
ysis, was also performed in all patients before discharge.
Clinical and echocardiographic follow-up assessments were
performed 1, 3, 6 and 12months after the procedure and
annually thereafter.
Results
Between January 2002 and December 2007, 73 consecutive
patients (11 adults) underwent an attempt at transcatheter
PDA closure in our unit. Ages ranged from 3months to
70 years, with a median age of 30months and a mean age
of 6.7± 10.5 years. The age distribution of the patients is
shown in Fig. 1. The mean weight was 21.5± 19.5 kg (range
3.3—85 kg).
An ADO was used in 50 patients (68%) and a DC in the
remaining 23 patients; one coil was placed in 22 patients,
while one patient required the deployment of two coils. The
prostheses were implanted successfully in all patients; no
device was wasted during the procedure and no patient was
sent for surgery subsequently. Mean ﬂuoroscopy durations
for DC and ADO were 6.5± 3 (range 3.2—13) min and 13.5± 4
(7.5—22) min, respectively.
At the narrowest point, the diameter of the ducts
ranged from 1.0 to 7.2mm, with a mean diameter of
2.9± 1.3mm. In the ADO group, the PDA was conical (type A)
F
i
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tigure 1. Age distribution and device use in the different age
roups.
n 43 patients, window-like (type B) in three patients, type C
n three patients and type D in one patient. In the DC group,
he PDA was conical in 17 patients, type E in three patients
nd type C in three patients.
Patients with an ADO had a mean age of 7.3± 8.2 years,
mean weight of 24.3± 20.0 kg and were signiﬁcantly older
nd heavier than patients with a DC, who had a mean
ge of 5.3± 14.3 years (p < 0.05) and a mean weight of
5.4± 16.8 kg (p < 0.05). These differences became even
ore signiﬁcant if the 70-year-old patient with a DC was
xcluded. Fig. 1 shows device use in the different age
roups.
In both groups, 6-month follow-up assessments were
ompleted scrupulously and systematically in all patients;
ollow-up duration ranged from 6.2months to 6.3 years, with
mean follow-up duration of 3.5± 1.8 years. In the ADO
roup, 20 (40%) patients had complete closure of the PDA
onﬁrmed angiographically, immediately after the proce-
ure. The next day, 28 additional patients (making a total of
6%) showed no evidence of residual shunt on colour Doppler
ow mapping. By the end of the ﬁrst month, the rate of com-
lete closure had reached 98% (49 patients) and remained
nchanged at the 6-month follow-up assessment. Only one
atient had a persistent residual shunt at 12months; the
DO had migrated asymptomatically to the abdominal aorta.
In the DC group, immediate occlusion of the PDA was
chieved in 12 (52%) patients. This rate rose to 74%
17 patients) 24 hours after the procedure and to 91%
21 patients) 1month later. At 6months, complete closure
as evident in all 23 patients. No patient in either group
howed signs of haemolysis on urinalysis.
echnical difﬁcultiesailure to obtain arterial access was encountered in two
nfants aged 19 and 24months (9 and 12 kg, respectively).
n both, the preprocedural aortogram had to be performed
hrough the PDA using a Multi-Track angiographic catheter
114 Z. Saliba et al.
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Bigure 2. A. Aortic angiogram in lateral projection showing the
. Repositioning the ADO by balloon inﬂation (white arrow) into the
NuMed, Hopkinton, NY, USA) mounted transvenously on a
uide wire. In the ﬁrst child, a DC was placed through
venous approach; in the second, an ADO was delivered
ransvenously as usual. In both cases, because access to
he aorta was impossible after duct closure, postoperative
chocardiography was used to assess the device position
fter its deployment. In two adults with large window-type
DAs, the measurement of the duct could not be determined
recisely by aortography using different projections. Balloon
izing of the duct was therefore performed and the size of
he device was chosen according to the measured diameter
f the occluding balloon; a 12/10ADO was used in both cases
o occlude a 7.0mm and a 7.2mm duct.
omplicationsevice-related minor complications occurred only in the
DO group, in four children all aged more than 15months
5.4%). Three of these patients, weighing 5, 6 and 10 kg,
howed a mild aortic narrowing from device protrusion into
he aortic isthmus (Fig. 2). The two youngest patients had a
2
o
s
l
igure 3. Angiogram showing protrusion of the ADO (white arrow) int
. Four-chamber view projection.(black arrow) protruding into the aortic isthmus (white arrow).
a.
ystolic gradient less than 10mmHg across the ADO and no
ystemic hypertension. The 10 kg patient had an initial gradi-
nt of 20mmHg; the device position was therefore partially
djusted during the same procedure, by pushing it with a
alloon catheter from the aorta, reducing the gradient to
0mmHg (Fig. 2B). In these three patients, the peak veloc-
ty across the isthmus on Doppler examination at 3months
as less than 2.5m/sec, without any systemic hyperten-
ion; the 10mmHg arm-to-leg systolic pressure gradient was
bsent. In the fourth patient (6months, 7 kg), who had a
inor device-related complication, the prosthesis was seen
rotruding into the left pulmonary artery (PA), producing an
bnormal ﬂow at a peak velocity of 2.7m/sec (Fig. 3). This
atient did not show any dissymmetry in pulmonary vascular-
sation on a perfusion scan performed 3months later during
he follow-up assessment; at that time, the peak velocity
cross the protruding device in the left PA had decreased to
.2m/sec.
There were three major complications in three (4.2%)
ther children. One patient (6months, 7 kg) experienced
evere bradycardia due to pulmonary air embolism, fol-
owing inadvertent retrieval of the delivery cable from
o the PA. A. Lateral view: the ductus is shown by the black arrow.
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the sheath after ADO releasing; the child recovered com-
pletely within a few minutes after resuscitation. The second
complication occurred in an infant (3months, 3.3 kg) who
experienced occlusion of the right femoral artery after the
procedure; this baby had a permanent asymptomatic occlu-
sion of the right femoral artery despite the aggressive use of
thrombolytic drugs as conﬁrmed by a Doppler study at the
6-month follow-up assessment. Limb growth was normal on
follow-up physical examinations; the child showed normal
gate at the age of 14months and the paediatric orthopaedic
professional conﬁrmed the absence of dissymmetry between
the right and left limbs at the age of 3 years.
The third complication, an ADO migration, was diagnosed
1 year later in a child (24months, 17 kg); an unusually large
residual shunt was noted on all the routine follow-up ultra-
sound examinations. A chest X-ray was performed ﬁnally at
12months and conﬁrmed the device migration in the abdom-
inal aorta. We believe that the embolization occurred on
the day after the procedure, as documented by the predis-
charge misinterpreted chest X-ray, which did not show the
radio-opaque markers of the ADO in the usual position. The
device was embedded asymptomatically in the abdominal
aorta, facing the coeliac artery. The attempt to remove it
percutaneously failed due to its strong adhesion to the aortic
wall. There were no related hemodynamic consequences, so
it was left in place and successful percutaneous PDA closure
was then achieved with another ADO.
Discussion
Excluding premature infants, there are actually very few
ducts that cannot be closed safely and effectively using tran-
scatheter techniques [11—14]. With increasing experience,
complications and failures have been reduced to a minimum
but not abolished completely, especially in small infants with
large ducts [2—6,10,13].
In this series, a high rate of procedural success was
recorded, regardless of patient age, ductal size or the kind
of device used, with an early overall occlusion rate as high
as 89%, rising to 98% at the 3-month follow-up assessment.
These ﬁndings are very similar to those published in larger
series [3,5—7,10,13,14]. Most patients had a conical-shaped
PDA, which is a rather favourable type, with a well-deﬁned
ampulla allowing easy placement and good anchoring of the
device without protrusion into any of the adjacent arterial
trunks.
Analysing the difﬁculties and challenges encountered in
this series, we think that with more experience, the ﬁrst
two out of the three major complications observed could
have been avoided. Pulmonary air embolism leading to tran-
sient cardiac arrest occurred in one infant. After detaching
the device, the operator assistant retrieved the delivery
cable forcefully from the large 7 F sheath, which aspirated
air into the sheath and consequently into the PA. This was
the eleventh patient in our series and for practical reasons
we were not as yet using the haemostatic valve. After ade-
quate resuscitation, the patient recovered completely and
was discharged 48 hours later with no residual shunt. This
avoidable complication shows us once again how essential it
is to follow the manufacturer’s instructions fully.
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Migration of an 8/6ADO device was seen in 3-year-old
hild (18 kg) with a very long (2 cm), bulbous, type D PDA
Fig. 4). This rare complication has been reported previ-
usly and is believed to occur immediately after or within
4 hours of the procedure [10,12,13,15,16]. In our patient,
he chest X-ray performed 24 hours after the procedure
as misinterpreted and the ADO was thought to be in its
sual position. The X-ray was not examined by the paedi-
tric cardiologist before discharge and the resident was not
ufﬁciently experienced to express any concern. Retrospec-
ively, we believe that the 8/6ADO device was undersized
n our patient and that the signiﬁcant residual parapros-
hetic shunt noted before releasing the device should have
lerted us to this mismatch problem. This residual shunt,
lthough unusually large, was thought to be adjacent to the
rosthesis and was watched for 12months with the hope of
pontaneous resolution. This highlights the need for careful
nd accurate immediate, intermediate and late follow-up
ssessments. The device is usually impossible to retrieve
ercutaneously when discovered late after the initial migra-
ion and may be left untouched if it remains asymptomatic
5,16,17]. Even with the help of an adult invasive radiolo-
ist experienced in the retrieval of endocaval ﬁlters, all our
ttempts at the retrieval of the device from the abdominal
orta were futile. Efforts were then redirected at PDA clo-
ure and surgery was contemplated seriously. However, as
any solutions have been proposed in cases of D type PDA,
e decided to continue with a percutaneous technique, i.e.
versizing the device by two or more sizes or using a vascu-
ar plug. We favour generous oversizing of the prosthesis and
ts deployment within the body of the duct, which allows for
ncomplete deployment of the disc and hence avoids tear-
ng of the ductal wall (Fig. 4C) [18]. This technique was used
2months later to close the PDA successfully in this patient,
ith a 14/12ADO.
The third major complication was the occlusion of the
emoral artery. Although palpated strongly, the femoral
ulse may be radiating, making it difﬁcult to locate
nd catheterize the femoral artery, especially in small
nfants. Multiple attempts at obtaining arterial access, cou-
led with the relatively large size of the delivery system
5F) may expose patients to potentially serious vascular
omplications; reduced pulse or occlusion of the femoral
rtery are sometimes reported in small infants [3]. In expe-
ienced hands, however, vascular access should be obtained
asily, especially with the aid of Doppler for more accu-
ate location of the artery. In our series, catheterization of
he femoral artery only proved difﬁcult in the early stages
f the learning curve and failure to obtain arterial access
as encountered in two patients. We do not use Doppler to
ocate the artery and are not familiar with its advantages
n the catheterization laboratory. Adequate heparinization
s critical but not sufﬁcient to avoid the complications men-
ioned above. Although not used in our practice, repeated
ctivated clotting time measurements during the procedure
re useful to ensure adequate heparinization.
Another challenge related to age is the adequate mea-
urement of very large window-like ducts in adult patients.
efore any duct closure, it is crucial to measure the min-
mum PDA diameter during systole, as this measurement
an be 30% larger than the diastolic dimension [19]. This
ariation becomes more signiﬁcant in larger ducts and
116 Z. Saliba et al.
F s typ
a f the
i
t
b
m
a
i
s
U
w
l
o
t
t
w
a
o
U
m
i
P
i
p
t
l
d
b
t
f
w
p
o
o
w
i
a
e
n
D
a
P
f
b
d
t
[
m
s
d
c
A
d
t
s
t
n
t
s
A
P
Rigure 4. A. Magnetic resonance image showing a type D (bulbou
nd a larger middle part. B. An aortogram showing a lateral view o
ncompletely deployed (black arrows) within the body of the duct.
he standard lateral view ﬂuoroscopy projections may not
e sufﬁcient for accurate measuring. We were unable to
easure a window-type duct in two adults accurately by
ngiography alone, despite the generous amount of dye
njected in different projections. Therefore, a complying
izing balloon (AGA medical corporation, Golden Valley, MN,
SA), conceived initially for atrial septal defect calibration,
as used to determine the precise duct diameter. The bal-
oon should be used very gently with no tension and retrieved
n a guide wire from the aorta across the duct by pushing
he wire and freeing the syringe. As a general rule, several
ypes of occluding devices should be available in all sizes
hen attempting percutaneous closure of a large duct in an
dult patient, as the precise size and shape of the PDA may
nly be uncovered in the catheterization laboratory [11].
se of the new generation magnetic resonance imaging or
ultislice computerized tomography has also been proposed
n adult patients to delineate the exact morphology of the
DA [4,11,19,20]. To our knowledge, difﬁculties in measur-
ng the PDA accurately have not been reported in paediatric
atients.
Device-related difﬁculties, such as an inability to posi-
ion the device in the ductal ampulla, problems related to
oading, deployment or retrieval, and malfunction of the
evice itself or any component of the delivery system, have
een reported rarely in large series [2,10,21]. Protrusion of
he ADO into the left PA or the aortic lumen occurred in
our patients in our series, all inferior to 18months old and
eighing inferior to 10 kg. This is in accordance with other
ublished reports [2,3,5,6,21—23]. In all four patients, rig-
rous and systematic follow-up assessments were carried
ut with regard to the obstruction. The isthmic obstruction
as evaluated by the gradient across the isthmus, measured
3
w
t
c
ie) PDA, with smaller aortic and pulmonary openings (black arrows)
same PDA. C. Lateral view aortogram showing the ADO purposely
nvasively initially and then by the peak Doppler velocity
nd the arm-to-leg systolic pressure ratio. The absence of
levated systemic blood pressure per se is a good sign of a
on-obstructed ﬂow. This may be conﬁrmed further by peak
oppler isthmic velocity less than 2.5m/sec and by equal
rm and leg systolic pressures. The concern about a left
A obstruction by an ADO prompted us to perform a per-
usion scan that showed normal ﬂow distribution between
oth lungs.
In some reported cases, the size mismatch between the
evice and the child has led to serious protrusion into
he descending aorta or PA, necessitating device retrieval
22,23]. Correction of the protrusion into the aortic isth-
us may be achieved by using a balloon or deploying a
tent to push and reposition the device inside the duct. This
elicate but feasible technique has been performed suc-
essfully by Ewert, Beck et al. and Moore et al. [4,19,22].
lthough conical morphology of the PDA is favourable for
evice accommodation, it does not prevent protrusion into
he adjacent vessels; in fact, in this series, all device protru-
ions occurred in conical-shaped PDAs. While the shape of
he device is unique, the PDA anatomy is like a ﬁngerprint;
o two are exactly the same and the length of the PDA or
he diameter of the aortic ampulla can widely vary in the
ame anatomy group. Thus, oversizing or undersizing the
DO, especially in small infants and even in conical-shaped
DAs, may lead to obstruction in either the aorta or the PA.
ecently, a special ADO device has been developed with a
2-degree angle between the plug and the retention disc,
hich corresponds better with the anatomic proportions of
he PDA and aortic isthmus. In addition, its aortic disc is
oncave toward the aorta, reducing any possible protrusion
nto the aortic lumen [2,13].
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Table 1 Difﬁculties and complications.
Age Weight (kg) Size (mm) Device
Difﬁculty (% of procedures)
Failure of arterial access (2.7%) 19months 9.0 1.5 DC
24months 12.0 2.6 ADO
Balloon sizing (2.7%) 23 years 65.0 7.0 ADO
28 years 67.0 7.2 ADO
Complication (% of procedures)
Device protrusion in aorta (4.1%) 15months 10.0 4.6 ADO
4months 5.0 2.0 ADO
6months 6.0 4.0 ADO
Device protrusion in PA (1.4%) 6months 7.0 3.2 ADO
Loss of femoral pulse (1.4%) 3months 3.3 1.5 DC
[
[
[
[
[
[
[Pulmonary air embolism (1.4%) 6months
Device embolization (1.4%) 24months
Conclusion
With experience, percutaneous PDA closure can give excel-
lent results when the appropriate device is chosen, with
no mortality and minimal morbidity rates. Moreover, when
protocols are followed carefully, most complications are
not life-threatening and are without long-term sequelae.
Accurate measurement remains the key for success. This
may necessitate balloon sizing in adults, or other imaging
radiology tools. Cautious surveillance for untoward events
is essential, especially in small infants with large ducts,
as they are at higher risk, potentially for both technical
and procedural problems. Scrupulous and systematic follow-
up assessments are of utmost importance to conﬁrm the
medium- and long-term success of the procedure. Future
studies should focus on developing smaller delivery systems
and creating devices adapted to all ductal morphologies.
Table 1.
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